Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Fatigue is highly prevalent in patients with COPD and correlates poorly with the degree of airflow limitation.

Goërtz YMJ, Spruit MA, Van 't Hul AJ, Peters JB, Van Herck M, Nakken N, Djamin RS, Burtin C, Thong MSY, Coors A, Meertens-Kerris Y, Wouters EFM, Prins JB, Franssen FME, Muris JWM, Vanfleteren LEGW, Sprangers MAG, Janssen DJA, Vercoulen JH.

Ther Adv Respir Dis. 2019 Jan-Dec;13:1753466619878128. doi: 10.1177/1753466619878128.

PMID:
31558115
2.

Pulmonary Rehabilitation Reduces Subjective Fatigue in COPD: A Responder Analysis.

Van Herck M, Antons J, Vercoulen JH, Goërtz YMJ, Ebadi Z, Burtin C, Janssen DJA, Thong MSY, Otker J, Coors A, Sprangers MAG, Muris JWM, Prins JB, Spruit MA, Peters JB.

J Clin Med. 2019 Aug 20;8(8). pii: E1264. doi: 10.3390/jcm8081264.

3.

Fatigue is Highly Prevalent in Patients with Asthma and Contributes to the Burden of Disease.

Van Herck M, Spruit MA, Burtin C, Djamin R, Antons J, Goërtz YMJ, Ebadi Z, Janssen DJA, Vercoulen JH, Peters JB, Thong MSY, Otker J, Coors A, Sprangers MAG, Muris JWM, Wouters EFM, van 't Hul AJ.

J Clin Med. 2018 Nov 23;7(12). pii: E471. doi: 10.3390/jcm7120471.

4.

Validation of ACCESS: an automated tool to support self-management of COPD exacerbations.

Boer LM, van der Heijden M, van Kuijk NM, Lucas PJ, Vercoulen JH, Assendelft WJ, Bischoff EW, Schermer TR.

Int J Chron Obstruct Pulmon Dis. 2018 Oct 10;13:3255-3267. doi: 10.2147/COPD.S167272. eCollection 2018.

5.

COPD stands for complex obstructive pulmonary disease.

Houben-Wilke S, Augustin IM, Vercoulen JH, van Ranst D, Bij de Vaate E, Wempe JB, Spruit MA, Wouters EFM, Franssen FME.

Eur Respir Rev. 2018 Jun 6;27(148). pii: 180027. doi: 10.1183/16000617.0027-2018. Print 2018 Jun 30. Review.

6.

Fatigue in patients with chronic obstructive pulmonary disease: protocol of the Dutch multicentre, longitudinal, observational FAntasTIGUE study.

Goërtz YMJ, Looijmans M, Prins JB, Janssen DJA, Thong MSY, Peters JB, Burtin C, Meertens-Kerris Y, Coors A, Muris JWM, Sprangers MAG, Wouters EFM, Vercoulen JH, Spruit MA.

BMJ Open. 2018 Apr 10;8(4):e021745. doi: 10.1136/bmjopen-2018-021745.

7.

'Exacerbation-free time' to assess the impact of exacerbations in patients with chronic obstructive pulmonary disease (COPD): a prospective observational study.

Boer LM, Bischoff EW, Borgijink X, Vercoulen JH, Akkermans RP, Kerstjens HAM, Assendelft WJ, Schermer TR.

NPJ Prim Care Respir Med. 2018 Apr 3;28(1):12. doi: 10.1038/s41533-018-0079-5.

8.

Knowledge gaps in patients with COPD and their proxies.

Nakken N, Janssen DJA, van den Bogaart EHA, Muris JWM, Vercoulen JH, Custers FL, Bootsma GP, Gronenschild MHM, Wouters EFM, Spruit MA.

BMC Pulm Med. 2017 Oct 30;17(1):136. doi: 10.1186/s12890-017-0481-8.

9.

Fatigue in COPD: an important yet ignored symptom.

Spruit MA, Vercoulen JH, Sprangers MAG, Wouters EFM; FAntasTIGUE consortium.

Lancet Respir Med. 2017 Jul;5(7):542-544. doi: 10.1016/S2213-2600(17)30158-3. Epub 2017 Apr 21. No abstract available.

PMID:
28438501
10.

Assessment of Burden of COPD (ABC) tool: perception versus evidence.

Houben-Wilke S, Franssen FM, Kok I, Otten HJ, Wempe JP, Vercoulen JH.

Eur Respir J. 2017 Mar 15;49(3). pii: 1602382. doi: 10.1183/13993003.02382-2016. Print 2017 Mar. No abstract available.

11.

Gender differences in partners of patients with COPD and their perceptions about the patients.

Nakken N, Janssen DJ, van Vliet M, de Vries GJ, Clappers-Gielen GA, Michels AJ, Muris JW, Vercoulen JH, Wouters EF, Spruit MA.

Int J Chron Obstruct Pulmon Dis. 2016 Dec 23;12:95-104. doi: 10.2147/COPD.S118871. eCollection 2017.

12.

Integral Health Status-Based Cluster Analysis in Moderate-Severe COPD Patients Identifies Three Clinical Phenotypes: Relevant for Treatment As Usual and Pulmonary Rehabilitation.

Peters JB, Boer LM, Molema J, Heijdra YF, Prins JB, Vercoulen JH.

Int J Behav Med. 2017 Aug;24(4):571-583. doi: 10.1007/s12529-016-9622-3.

13.

Definition of a COPD self-management intervention: International Expert Group consensus.

Effing TW, Vercoulen JH, Bourbeau J, Trappenburg J, Lenferink A, Cafarella P, Coultas D, Meek P, van der Valk P, Bischoff EW, Bucknall C, Dewan NA, Early F, Fan V, Frith P, Janssen DJ, Mitchell K, Morgan M, Nici L, Patel I, Walters H, Rice KL, Singh S, Zuwallack R, Benzo R, Goldstein R, Partridge MR, van der Palen J.

Eur Respir J. 2016 Jul;48(1):46-54. doi: 10.1183/13993003.00025-2016. Epub 2016 Apr 13.

14.

Surprisingly few psychological problems and diabetes-related distress in patients with poor glycaemic control.

Bazelmans E, Netea-Maier RT, Vercoulen JH, Tack CJ.

Neth J Med. 2016 Jan;74(1):16-21.

15.

Health Status and Morbidities in Resident Relatives of Patients With COPD.

Nakken N, Spruit MA, van den Bogaart EH, van Vliet M, de Vries GJ, Custers FL, Vercoulen JH, Asijee GM, Muris JW, Vanfleteren LE, Franssen FM, Wouters EF, Janssen DJ.

J Am Med Dir Assoc. 2016 Mar 1;17(3):276.e1-8. doi: 10.1016/j.jamda.2015.12.012. Epub 2016 Jan 21.

PMID:
26805754
16.

Persistence of impaired health status of Q fever patients 4 years after the first Dutch outbreak.

Limonard GJ, Peters JB, Besselink R, Groot CA, Dekhuijzen PN, Vercoulen JH, Nabuurs-Franssen MH.

Epidemiol Infect. 2016 Apr;144(6):1142-7. doi: 10.1017/S0950268815002216. Epub 2015 Oct 28.

PMID:
26508155
17.

Informal caregivers of patients with COPD: Home Sweet Home?

Nakken N, Janssen DJ, van den Bogaart EH, Wouters EF, Franssen FM, Vercoulen JH, Spruit MA.

Eur Respir Rev. 2015 Sep;24(137):498-504. doi: 10.1183/16000617.00010114. Review.

18.

Work participation in Q-fever patients and patients with Legionnaires' disease: a 12-month cohort study.

Van Loenhout JA, Hautvast JL, Akkermans RP, Donders NC, Vercoulen JH, Paget WJ, van der Velden K.

Scand J Public Health. 2015 May;43(3):294-301. doi: 10.1177/1403494815571030. Epub 2015 Feb 27.

PMID:
25724468
19.

Q-fever patients suffer from impaired health status long after the acute phase of the illness: results from a 24-month cohort study.

van Loenhout JA, Hautvast JL, Vercoulen JH, Akkermans RP, Wijkmans CJ, van der Velden K, Paget WJ.

J Infect. 2015 Mar;70(3):237-46. doi: 10.1016/j.jinf.2014.10.010. Epub 2014 Nov 1.

PMID:
25452036
20.

An observational, longitudinal study on the home environment of people with chronic obstructive pulmonary disease: the research protocol of the Home Sweet Home study.

Nakken N, Janssen DJ, van den Bogaart EH, Vercoulen JH, Wouters EF, Spruit MA.

BMJ Open. 2014 Nov 10;4(11):e006098. doi: 10.1136/bmjopen-2014-006098.

21.

Serious long-term health consequences of Q-fever and Legionnaires' disease.

van Loenhout JA, van Tiel HH, van den Heuvel J, Vercoulen JH, Bor H, van der Velden K, Paget WJ, Hautvast JL.

J Infect. 2014 Jun;68(6):527-33. doi: 10.1016/j.jinf.2014.01.004. Epub 2014 Jan 25.

PMID:
24468188
22.

Health status measurement in patients with severe asthma.

Peters JB, Rijssenbeek-Nouwens LH, Bron AO, Fieten KB, Weersink EJ, Bel EH, Vercoulen JH.

Respir Med. 2014 Feb;108(2):278-86. doi: 10.1016/j.rmed.2013.11.012. Epub 2013 Dec 3.

23.

An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation.

Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, Hill K, Holland AE, Lareau SC, Man WD, Pitta F, Sewell L, Raskin J, Bourbeau J, Crouch R, Franssen FM, Casaburi R, Vercoulen JH, Vogiatzis I, Gosselink R, Clini EM, Effing TW, Maltais F, van der Palen J, Troosters T, Janssen DJ, Collins E, Garcia-Aymerich J, Brooks D, Fahy BF, Puhan MA, Hoogendoorn M, Garrod R, Schols AM, Carlin B, Benzo R, Meek P, Morgan M, Rutten-van Mölken MP, Ries AL, Make B, Goldstein RS, Dowson CA, Brozek JL, Donner CF, Wouters EF; ATS/ERS Task Force on Pulmonary Rehabilitation.

Am J Respir Crit Care Med. 2013 Oct 15;188(8):e13-64. doi: 10.1164/rccm.201309-1634ST. Erratum in: Am J Respir Crit Care Med. 2014 Jun 15;189(12):1570.

PMID:
24127811
24.

Assessing health status and quality of life of Q-fever patients: the Nijmegen Clinical Screening Instrument versus the Short Form 36.

van Loenhout JA, Paget WJ, Sandker GW, Hautvast JL, van der Velden K, Vercoulen JH.

Health Qual Life Outcomes. 2013 Jul 4;11:112. doi: 10.1186/1477-7525-11-112.

25.

Assessing the stages of the grieving process in chronic obstructive pulmonary disease (COPD): validation of the Acceptance of Disease and Impairments Questionnaire (ADIQ).

Boer LM, Daudey L, Peters JB, Molema J, Prins JB, Vercoulen JH.

Int J Behav Med. 2014 Jun;21(3):561-70. doi: 10.1007/s12529-013-9312-3.

PMID:
23645551
26.

Resting and ADL-induced dynamic hyperinflation explain physical inactivity in COPD better than FEV1.

Lahaije AJ, van Helvoort HA, Dekhuijzen PN, Vercoulen JH, Heijdra YF.

Respir Med. 2013 Jun;107(6):834-40. doi: 10.1016/j.rmed.2013.02.017. Epub 2013 Mar 17.

27.

The use of regression equations to estimate peak work rate in people with COPD -reply from the authors.

Sillen MJ, Vercoulen JH, van 't Hul AJ, Klijn PH, Wouters EF, van Ranst D, Peters JB, van Keimpema AR, Franssen FM, Otten HJ, Molema J, Jansen JJ, Spruit MA.

COPD. 2013 Feb;10(1):120-1. doi: 10.3109/15412555.2012.736310. Epub 2012 Dec 28. No abstract available.

PMID:
23272669
28.

Comprehensive self management and routine monitoring in chronic obstructive pulmonary disease patients in general practice: randomised controlled trial.

Bischoff EW, Akkermans R, Bourbeau J, van Weel C, Vercoulen JH, Schermer TR.

BMJ. 2012 Nov 28;345:e7642. doi: 10.1136/bmj.e7642.

29.

[Working with the Dutch Standard of Care for COPD: using the 'Nijmegen Clinical Screening Instrument' as an aid].

Vercoulen JH, Bischoff EW, Heijdra YF.

Ned Tijdschr Geneeskd. 2012;156(45):A4919. Dutch.

PMID:
23134747
30.

A simple method to enable patient-tailored treatment and to motivate the patient to change behaviour.

Vercoulen JH.

Chron Respir Dis. 2012;9(4):259-68. doi: 10.1177/1479972312459974. Review.

PMID:
23129804
31.

Assessing the long-term health impact of Q-fever in the Netherlands: a prospective cohort study started in 2007 on the largest documented Q-fever outbreak to date.

van Loenhout JA, Paget WJ, Vercoulen JH, Wijkmans CJ, Hautvast JL, van der Velden K.

BMC Infect Dis. 2012 Oct 30;12:280. doi: 10.1186/1471-2334-12-280.

32.

Decline of health status sub-domains by exacerbations of chronic obstructive pulmonary disease: a prospective survey.

Verhage T, Boer L, Molema J, Heijdra Y, Dekhuijzen R, Vercoulen JH.

Respiration. 2013;85(3):236-43. doi: 10.1159/000339925. Epub 2012 Aug 22.

33.

Inaccuracy of estimating peak work rate from six-minute walk distance in patients with COPD.

Sillen MJ, Vercoulen JH, van 't Hul AJ, Klijn PH, Wouters EF, van Ranst D, Peters JB, van Keimpema AR, Franssen FM, Otten HJ, Molema J, Jansen JJ, Spruit MA.

COPD. 2012 Jun;9(3):281-8. doi: 10.3109/15412555.2012.655866. Epub 2012 Feb 23.

PMID:
22360382
34.

How about your peers? Cystic fibrosis questionnaire data from healthy children and adolescents.

Tibosch MM, Sintnicolaas CJ, Peters JB, Merkus PJ, Yntema JB, Verhaak CM, Vercoulen JH.

BMC Pediatr. 2011 Oct 11;11:86. doi: 10.1186/1471-2431-11-86.

35.

Validity of an automated telephonic system to assess COPD exacerbation rates.

Bischoff EW, Boer LM, Molema J, Akkermans R, van Weel C, Vercoulen JH, Schermer TR.

Eur Respir J. 2012 May;39(5):1090-6. doi: 10.1183/09031936.00057811. Epub 2011 Sep 15.

36.

The health status of Q-fever patients after long-term follow-up.

Morroy G, Peters JB, van Nieuwenhof M, Bor HH, Hautvast JL, van der Hoek W, Wijkmans CJ, Vercoulen JH.

BMC Infect Dis. 2011 Apr 18;11:97. doi: 10.1186/1471-2334-11-97.

37.

Course of normal and abnormal fatigue in patients with chronic obstructive pulmonary disease, and its relationship with domains of health status.

Peters JB, Heijdra YF, Daudey L, Boer LM, Molema J, Dekhuijzen PN, Schermer TR, Vercoulen JH.

Patient Educ Couns. 2011 Nov;85(2):281-5. doi: 10.1016/j.pec.2010.08.021. Epub 2010 Sep 29.

PMID:
20884162
38.

Detailed analysis of health status of Q fever patients 1 year after the first Dutch outbreak: a case-control study.

Limonard GJ, Peters JB, Nabuurs-Franssen MH, Weers-Pothoff G, Besselink R, Groot CA, Dekhuijzen PN, Vercoulen JH.

QJM. 2010 Dec;103(12):953-8. doi: 10.1093/qjmed/hcq144. Epub 2010 Aug 27.

PMID:
20802011
39.

Health status in COPD cannot be measured by the St George's Respiratory Questionnaire alone: an evaluation of the underlying concepts of this questionnaire.

Daudey L, Peters JB, Molema J, Dekhuijzen PN, Prins JB, Heijdra YF, Vercoulen JH.

Respir Res. 2010 Jul 22;11:98. doi: 10.1186/1465-9921-11-98.

40.

Maximal exercise capacity in chronic obstructive pulmonary disease: a limited indicator of the health status.

Verhage TL, Vercoulen JH, van Helvoort HA, Peters JB, Molema J, Dekhuijzen PN, Heijdra YF.

Respiration. 2010;80(6):453-62. doi: 10.1159/000295920. Epub 2010 Mar 11.

41.

Development of a battery of instruments for detailed measurement of health status in patients with COPD in routine care: the Nijmegen Clinical Screening Instrument.

Peters JB, Daudey L, Heijdra YF, Molema J, Dekhuijzen PN, Vercoulen JH.

Qual Life Res. 2009 Sep;18(7):901-12. doi: 10.1007/s11136-009-9502-2. Epub 2009 Jun 19.

42.

Adequate Patient Characterization in COPD: Reasons to Go Beyond GOLD Classification.

Verhage TL, Heijdra YF, Molema J, Daudey L, Dekhuijzen PN, Vercoulen JH.

Open Respir Med J. 2009 Feb 13;3:1-9. doi: 10.2174/1874306400903010001.

43.

An Integral assessment framework of health status in chronic obstructive pulmonary disease (COPD).

Vercoulen JH, Daudey L, Molema J, Vos PJ, Peters JB, Top M, Folgering H.

Int J Behav Med. 2008;15(4):263-79. doi: 10.1080/10705500802365474.

PMID:
19005926
44.

Knowledge about asthma and COPD: associations with sick leave, health complaints, functional limitations, adaptation, and perceived control.

Boot CR, van der Gulden JW, Vercoulen JH, van den Borne BH, Orbon KH, Rooijackers J, van Weel C, Folgering HT.

Patient Educ Couns. 2005 Oct;59(1):103-9.

PMID:
16198224
45.

Sick leave in workers with asthma and COPD: the role of attitudes, perceived social norms and self efficacy.

Boot CR, Vercoulen JH, van der Gulden JW, van den Borne BH, Orbon KH, van Weel C, Folgering HT.

Patient Educ Couns. 2005 Aug;58(2):192-8.

PMID:
16009296
46.

Predictors of changes in sick leave in workers with asthma: a follow-up study.

Boot CR, Vercoulen JH, van der Gulden JW, Orbon KH, Rooijackers JM, van Weel C, Folgering HT.

Int Arch Occup Environ Health. 2005 Sep;78(8):633-40. Epub 2005 Oct 12.

PMID:
16001208
47.

Sick leave in patients with obstructive lung disease is related to psychosocial and work variables rather than to FEV1.

Boot CR, Vercoulen JH, van der Gulden JW, Orbon KH, van den Hoogen H, Folgering HT.

Respir Med. 2005 Aug;99(8):1022-31. Epub 2005 Mar 21.

48.

Asthma and chronic obstructive pulmonary disease: differences between workers with and without sick leave.

Boot CR, van der Gulden JW, Orbon KH, Vercoulen JH, Akkermans R, van Weel C, Folgering HT.

Int Arch Occup Environ Health. 2004 Jun;77(5):357-62. Epub 2004 Apr 24.

PMID:
15108002
49.

Identifying physical activity patterns in chronic fatigue syndrome using actigraphic assessment.

van der Werf SP, Prins JB, Vercoulen JH, van der Meer JW, Bleijenberg G.

J Psychosom Res. 2000 Nov;49(5):373-9.

PMID:
11164063
50.

Measurement of prolonged fatigue in the working population: determination of a cutoff point for the checklist individual strength.

Bültmann U, de Vries M, Beurskens AJ, Bleijenberg G, Vercoulen JH, Kant I.

J Occup Health Psychol. 2000 Oct;5(4):411-6.

PMID:
11051524

Supplemental Content

Loading ...
Support Center